- 01Well tolerated is not the same as proven to help
Milk thistle's safety record is reassuring: LiverTox has not linked it to liver injury, and trial side effects match placebo. Its effectiveness record is weak: the best-designed US trials, at three or more times the usual dose, did not lower ALT in hepatitis C or meet their main goal in fatty liver. People often read the first fact as evidence for the second.
- 02A normal-feeling liver can still have abnormal tests
Milk thistle is often bought by people with a raised ALT or a fatty liver on a scan. Those findings need a clinician to find the cause (alcohol, weight and blood sugar, medicines, hepatitis viruses and others), and a supplement can delay that work without fixing what drives it.
Milk thistle (Silybum marianum) is a purple-flowered Mediterranean herb whose seeds hold silymarin, a group of plant compounds led by silybin, and it has been used for centuries as a liver tonic 1. The trials have not kept pace with the reputation. In the largest US trials, high doses of silymarin did not lower ALT (alanine aminotransferase, a liver enzyme on routine blood tests) in hepatitis C and did not meet the main goal in fatty liver 45. Small trials suggest a modest drop in blood sugar in type 2 diabetes 8. What milk thistle does have is a clean safety record: LiverTox has not linked it to liver injury 1.
What is milk thistle?
Milk thistle is a herb whose seed extract holds a group of plant compounds known together as silymarin, made up mainly of silybin (also spelled silibinin) 1. For the basics, what it is and what it does in your body has its own page, and this guide covers the evidence, how much studies use, when and how to take it, its forms, side effects and interactions.
In lab and animal studies, silymarin protects liver cells from toxins including acetaminophen and the death cap mushroom (Amanita phalloides) 1. An intravenous form of purified silybin is approved in Europe for death cap mushroom poisoning, a hospital use with no published controlled trials 1. Death cap poisoning is a medical emergency, and capsules have no role in it.
Supplements are usually seed extracts standardized to a stated percentage of silymarin (80% in the LifeFrom product), sometimes combined with ground whole seed. LiverTox lists typical products at 250 to 750 mg of extract, taken 2 to 3 times a day 1.
What milk thistle is good for: the evidence, graded
Each use below carries a grade. Strong means several good randomized trials or a meta-analysis agree. Moderate means several randomized trials, mostly positive but small or short. Limited means few or small trials, or mixed results. Early means lab, animal or a single pilot study. Not supported means good trials found no benefit. Our guide to how supplements are regulated and studied explains the difference between a tradition and a trial.
| Use | What the research found | Evidence | Source |
|---|---|---|---|
| ALT in chronic hepatitis C | 154 people, 24 weeks at 1,260 or 2,100 mg a day: ALT fell no more than with placebo | Not supported | 4 |
| Survival in alcohol-related or viral liver disease | 18 trials, 1,088 patients, mostly low quality: no effect on death overall (relative risk 0.78, not significant) | Not supported | 3 |
| Fatty liver with inflammation (NASH) | Two 48-week biopsy trials: main goal missed in both; one found less scarring as a secondary result | Limited | 56 |
| Liver enzymes in fatty liver, pooled | 26 trials, 2,375 patients: lower ALT and AST, but the authors call for confirmation | Limited | 7 |
| Blood sugar in type 2 diabetes | One 4-month trial of 51 people: lower HbA1c and fasting glucose; a 16-study meta-analysis agreed | Limited | 89 |
| Cholesterol | Pooled trials in fatty liver and in metabolic conditions: lower total and LDL cholesterol | Limited | 79 |
| Death cap mushroom poisoning | Intravenous silybin is used in European hospitals; no published controlled trials | Early (hospital only) | 1 |
What does milk thistle do for the liver?
NCCIH, the federal agency for complementary health research, sums it up plainly: there is not enough high-quality evidence for firm conclusions about milk thistle for any health condition 2. LiverTox puts the human research the same way.
Controlled trials of silymarin in chronic hepatitis C and nonalcoholic fatty liver disease found little or no evidence of benefit in ameliorating disease activity or in slowing disease progression.
The clearest test was the SyNCH hepatitis C trial. It enrolled 154 people whose hepatitis C had not responded to interferon treatment and whose ALT was 65 U/L or higher, and gave them 420 mg or 700 mg of silymarin three times a day, or placebo, for 24 weeks. Only 2 people in each group reached the ALT goal, and the average ALT drop did not differ between groups (4.3 U/L on placebo, 14.4 and 11.3 U/L on the two doses, all within the range of chance) 4.
The older evidence points the same way. A Cochrane review pooled 18 randomized trials in 1,088 people with alcohol-related liver disease or hepatitis B or C. Milk thistle had no significant effect on death (relative risk 0.78), on liver complications, or on liver biopsy findings. Liver-related deaths looked lower across all trials but not in the high-quality ones, and only 28.6% of the trials reported high methodological quality 3.
Milk thistle and fatty liver
Fatty liver (now often called MASLD, metabolic dysfunction-associated steatotic liver disease) is where milk thistle is most hopeful, and still unproven. A Malaysian trial gave 99 adults with biopsy-proven NASH (fatty liver with inflammation) 700 mg of silymarin or placebo three times a day for 48 weeks. The main goal, a 30% drop in a liver activity score, was not met: 32.7% vs 26.0%. Scarring did improve more often on silymarin, though: fibrosis (scarring) improved by a stage or more in 22.4% on silymarin against 6.0% on placebo 6.
A US trial of 78 adults with NASH tested 420 mg or 700 mg three times a day for 48 weeks. The main goal was reached by 15% and 19% on silymarin and 12% on placebo, no real difference, and scarring improved most in the placebo group 5. A 2024 meta-analysis of 26 trials and 2,375 patients reported lower ALT and AST and better scan-based fat scores, while noting the effects need confirmation 7. Many of the pooled trials were small and not blinded.
Blood sugar
In a 4-month Iranian trial, 51 adults with type 2 diabetes took 200 mg of silymarin three times a day or placebo alongside their usual treatment. HbA1c (the three-month blood sugar average), fasting blood glucose, total and LDL cholesterol, triglycerides and liver enzymes all fell more on silymarin 8. A 2020 meta-analysis of 16 studies and 1,358 patients with blood sugar or cholesterol problems also found lower fasting glucose, HbA1c and LDL 9. NCCIH notes that most of this research was done in Middle Eastern countries and calls the evidence too thin for conclusions 2.
Type 2 diabetes and prediabetes are diagnosed and treated by a clinician, and milk thistle is not a treatment for either. If you already take diabetes medicine, any extra lowering of blood sugar matters, which is why it belongs in a conversation with the prescriber first. Our guide to blood sugar tests explains fasting glucose, HbA1c and insulin resistance.
Cholesterol
Lower total and LDL cholesterol appear in pooled analyses of trials in fatty liver and in metabolic conditions 79, but cholesterol was a secondary measure in most of them, and the effect sizes were reported on standardized scales that do not translate cleanly into mg/dL. If cholesterol is the reason you are reading, artichoke leaf has more direct lipid trials, and high cholesterol is managed by a clinician.
How much milk thistle do studies use?
These are the amounts trials used, recorded as research history, not a dose for anyone reading. Milk thistle is not a nutrient, so there is no recommended intake and no official upper limit. LiverTox notes it is well tolerated even in high daily doses 1.
| Use studied | Amount of silymarin | Form | Duration | Source |
|---|---|---|---|---|
| Chronic hepatitis C | 420 mg or 700 mg three times a day (1,260 or 2,100 mg a day) | Standardized extract (Legalon) | 24 weeks | 4 |
| NASH, US trial | 420 mg or 700 mg three times a day | Standardized extract (Legalon) | 48 weeks | 5 |
| NASH, Malaysian trial | 700 mg three times a day (2,100 mg a day) | Standardized extract | 48 weeks | 6 |
| Type 2 diabetes | 200 mg three times a day (600 mg a day) | Tablets | 4 months | 8 |
| Drug interaction study | 140 mg three times a day | Extract | 14 days | 10 |
| Typical retail products | 250 to 750 mg of extract, 2 to 3 times a day | Capsules or tablets | Ongoing | 1 |
One LifeFrom capsule holds 250 mg of seed extract standardized to 80% silymarin, which works out to about 200 mg of silymarin, plus 200 mg of ground whole seed. That is about a third of the 600 mg a day in the diabetes trial and a tenth or less of the 1,260 to 2,100 mg a day used in the US liver trials 48.
When and how to take milk thistle
How milk thistle was taken in studies
Trials and typical products split milk thistle into two or three doses a day 14. Blood levels of silymarin's parts differed between people with fatty liver and people with hepatitis C in a pharmacokinetic (drug-handling) study, so the same capsule may not behave the same in everyone 11.
How long does milk thistle take to work? In trials that measured anything, the changes were checked after 4 months for blood sugar 8 and after 48 weeks for liver biopsies 56. If a clinician is tracking a liver or blood sugar number, the trials suggest months, not weeks, before a change could be judged. No study has tested cycling it on and off.
Forms of milk thistle
| Form | What it is | What it is used for |
|---|---|---|
| Standardized seed extract | Seed extract concentrated to a stated silymarin percentage | Almost all trials, at hundreds to thousands of mg of silymarin a day 48 |
| Ground whole seed | The dried seed, with silymarin plus fiber and oil | Traditional use; amount of silymarin is lower and less consistent |
| Intravenous silybin | Purified silybin given by drip | Death cap mushroom poisoning in European hospitals only 1 |
Some products bind silybin to phosphatidylcholine (sold as a phytosome), marketed as better absorbed; none of the trials in this guide used that form, and the LifeFrom product is a standard extract plus whole seed.
Milk thistle side effects
In the large trials, side effects on silymarin matched placebo, even at 2,100 mg a day 45, and the Cochrane review found no rise in adverse events (relative risk 0.83) 3. LiverTox has not linked milk thistle to raised liver enzymes or clinically apparent liver injury 1.
| Common and usually mild | Less common, needs prompt care |
|---|---|
| Bloating, nausea and gas 2 | Hives, swelling of the face, lips or throat, wheezing: call 911 for throat swelling or trouble breathing 2 |
| Shakiness, sweating or confusion while on a diabetes medicine, which can mean low blood sugar: same-day care | |
| Dark urine, yellow eyes or skin, or pain under the right ribs: stop the supplement and get same-day care, since these need a medical explanation |
NCCIH also raises concerns about the chemical and microbiological quality of some milk thistle products 2. Choosing products tested by an independent lab is one way to know the capsule holds what the label says.
Who should avoid milk thistle or ask first
- Pregnancy and breastfeeding: NCCIH says little is known about whether milk thistle is safe during pregnancy or while breastfeeding 2. Ask your obstetric clinician first.
- Allergy to daisy-family plants: people allergic to ragweed, chrysanthemum, marigold or daisy are more likely to react 2.
- Diabetes: blood sugar effects in trials could add to insulin or other diabetes medicines 8.
- Diagnosed liver disease: milk thistle is not a treatment, and liver disease needs specialist care; ask the hepatologist before adding anything.
- Children: research is limited to small trials in specific medical settings; ask the child's clinician.
- Surgery: no specific surgical warning was found in the sources reviewed; tell the surgical team about every supplement, and blood sugar changes matter around surgery.
Milk thistle interactions
LiverTox notes that silymarin affects liver drug-processing enzymes (the cytochrome P450 family) and transporters in the lab, but that there is little evidence of clinically significant herb-drug interactions in people 1. The table covers the ones with some human signal.
| Medicine | What can happen | Why | What to do |
|---|---|---|---|
| Losartan (blood pressure) | Less conversion to its active form in one 12-person study | Silymarin slowed the CYP2C9 enzyme that activates losartan 10 | Ask the prescriber or pharmacist before combining |
| Insulin and other diabetes medicines | Blood sugar could fall further | Silymarin lowered HbA1c and fasting glucose in diabetes trials 89 | Talk to the prescriber first; they may want closer glucose checks |
| Other medicines cleared by CYP2C9 or CYP3A4 | Possible small changes in levels | Lab effects on these enzymes; little evidence in people 1 | Ask a pharmacist to check your full list |
Supplements to pair with milk thistle or keep apart
No study has set a gap in hours between milk thistle and another supplement, so this table flags overlaps. Everything in a pouch is taken at once.
| Supplement | Together or apart | Why |
|---|---|---|
| Berberine | Ask first before combining | Both are studied for lowering blood sugar, so effects could add up, especially with diabetes medicine 8 |
| Artichoke leaf | Overlap | Both are sold for the liver and cholesterol; artichoke leaf has its own caution for bile duct and gallbladder problems |
| NAC | Overlap | Both are sold for the liver; neither is a treatment for liver disease, and stacking liver products can delay getting an abnormal test explained |
| Green tea extract | Ask first | Concentrated green tea extract has its own liver-injury warnings; adding milk thistle does not offset them |
| Turmeric | Ask first | Also sold for the liver and has its own liver and bleeding cautions; see its guide |
Blood tests worth knowing about
No blood test measures milk thistle. The tests below are the ones the trials moved or the ones a clinician uses to watch the liver and blood sugar. Ask your clinician whether any of them make sense for you.
| Marker | Why it matters with milk thistle | When it is usually checked |
|---|---|---|
| ALT | The main liver test in the trials; fell in some small studies, not in the large hepatitis C trial 47 | Routine metabolic or liver panel |
| AST | Fell in pooled fatty liver trials 7; read with ALT and the AST to ALT ratio | Routine liver panel |
| GGT | A liver and bile-duct enzyme that helps a clinician sort out the cause of raised ALT | When liver tests are abnormal |
| Fasting glucose | Fell in diabetes trials 8; a low reading on diabetes medicine matters | Routine checkups, diabetes care |
| HbA1c | The three-month blood sugar average that fell in the diabetes trial 8 | Every 3 to 6 months in diabetes care |
| LDL cholesterol | Lower in pooled trials 79 | Lipid panel |
A high ALT is a reason to find the cause with a clinician, not to start milk thistle. For blood sugar, the HOMA-IR calculator estimates insulin resistance from fasting glucose and insulin, and the A1c calculator converts HbA1c to an average glucose. Our guide to reading a lipid panel covers LDL.
Conditions and goals milk thistle comes up around
Milk thistle is searched most alongside the liver, blood sugar and cholesterol. Fatty liver, prediabetes and high cholesterol are each diagnosed from blood tests or imaging and managed by a clinician. Milk thistle is not a treatment for any of them, and it is never a swap for a prescribed medicine. The trials above describe what happened to measurements in study groups, which is not a promise for any one person.
Milk thistle in the LifeFrom pouch
| In the LifeFrom pouch | |
|---|---|
| Product | Milk Thistle |
| What one serving holds | 1 capsule: Milk thistle seed extract (80% silymarin), 250 mg; Milk thistle seed (Silybum marianum), 200 mg |
| Form | Capsule; vegan capsule (vegetable cellulose) |
| How it is packed | One serving in each of your 30 daily pouches, with up to 8 supplements per pouch |
| Price | $9.00 a month, plus the fixed $28.50 a month packing, handling and US delivery line for the whole pouch, not per supplement. Prices as of November 2026; the shop shows the current price |
| Curated packs that include it | None |
One capsule supplies about 200 mg of silymarin from the extract, plus whole seed. That is lower than every trial dose above: about a third of the 600 mg a day in the diabetes trial and a tenth or less of the US liver trials 48. The label suggests taking it with meals, which fits a morning pouch taken with breakfast. See the shop and its packs.
This guide is general education, not medical advice, and it cannot diagnose you. Dietary supplements, milk thistle included, are not approved by the FDA for safety or effectiveness before they are sold. The clinician who knows your history and medicines is the right person to decide whether milk thistle fits, especially if you have a liver condition. Read our medical disclaimer for more.
Citations
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Milk Thistle. National Institute of Diabetes and Digestive and Kidney Diseases (NCBI Bookshelf), updated 21 January 2020.
- National Center for Complementary and Integrative Health (NIH). Milk Thistle: Usefulness and Safety. Updated February 2025.
- Rambaldi A, Jacobs BP, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev. 2007;(4):CD003620.
- Fried MW, Navarro VJ, Afdhal N, et al. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA. 2012;308(3):274-282.
- Navarro VJ, Belle SH, D'Amato M, et al. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial. PLoS One. 2019;14(9):e0221683.
- Wah Kheong C, Nik Mustapha NR, Mahadeva S. A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2017;15(12):1940-1949.
- Li S, Duan F, Li S, Lu B. Administration of silymarin in NAFLD/NASH: a systematic review and meta-analysis. Ann Hepatol. 2024;29(2):101174.
- Huseini HF, Larijani B, Heshmat R, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006;20(12):1036-1039.
- Xiao F, Gao F, Zhou S, Wang L. The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: a meta-analysis. Medicine (Baltimore). 2020;99(40):e22249.
- Han Y, Guo D, Chen Y, et al. Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers. Eur J Clin Pharmacol. 2009;65(6):585-591.
- Schrieber SJ, Wen Z, Vourvahis M, et al. The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic fatty liver disease and correlates with plasma caspase-3/7 activity. Drug Metab Dispos. 2008;36(9):1909-1916.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.
